Systemic Sclerosis (Scleroderma) and Raynaud's Phenomenon

Janet E. Pope, Philip J. Clements, Daniel E. Furst, Laura Hummers, Dinesh Khanna, Maureen D. Mayes, Thomas Medsger, James Seibold, Virginia Steen

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Systemic sclerosis (scleroderma; SSc) is a chronic con nective tissue disease characterized by inflammation within, and fibrosis of, the skin, vascular abnormalities, visceral damage, and the production of autoantibodies. SSc is divided generally into limited and diffuse forms, based on the extent of skin involvement. A group of conditions known as "localized" sclero-derma, which includes morphea, linear scleroderma, and en coup de sabre, is discussed in the chapter on Scleroderma Mimickers (Chap. 11). Diffuse SSc has a greater extent of skin involvement and is more likely to be associated with renal crisis, pulmonary fibrosis, and cardiomyopathy. Patients with diffuse SSc have a higher mortality rate. Pulmonary disease remains a major source of morbidity and mortality for patients with SSc. Patients with limited SSc are predisposed to the development of pulmonary arterial hypertension (PAH). Those with diffuse SSc are predisposed to interstitial fibrosis. Autoantibody profiles can predict to a certain extent the types of organ involvement that can be expected in SSc. Raynaud's phenomenon (RP) is characterized by vasospasm of the digital arteries that leads to well-demarcated pallor with cyanosis and rubor. RP is essentially universal among patients with SSc and is the first symptom in a large majority of patients. Primary RP is often mild enough not to require treatment; however, with secondary RP from SSc, there is not only vasospasm but also fixed blood vessel problems with luminal narrowing, so the ischemia can be more severe. Complications of RP in SSc can include digital ulcers often leading to infection and amputation causing pain and functional disability. Diffuse SSc often presents with puffiness of the hands associated with pain, in a way that can mimic rheumatoid arthritis. RP often occurs around the time of development of puffy hands in diffuse SSc.

Original languageEnglish (US)
Title of host publicationA Clinician's Pearls and Myths in Rheumatology
PublisherSpringer London
Pages77-95
Number of pages19
ISBN (Print)9781848009332
DOIs
StatePublished - 2009

Fingerprint

Raynaud Disease
Systemic Scleroderma
Localized Scleroderma
Autoantibodies
Blood Vessels
Fibrosis
Hand
Skin Abnormalities
Pallor
Pain
Skin
Cyanosis
Mortality
Pulmonary Fibrosis
Cardiomyopathies
Amputation
Pulmonary Hypertension
Lung Diseases
Ulcer
Rheumatoid Arthritis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pope, J. E., Clements, P. J., Furst, D. E., Hummers, L., Khanna, D., Mayes, M. D., ... Steen, V. (2009). Systemic Sclerosis (Scleroderma) and Raynaud's Phenomenon. In A Clinician's Pearls and Myths in Rheumatology (pp. 77-95). Springer London. https://doi.org/10.1007/978-1-84800-934-9_10

Systemic Sclerosis (Scleroderma) and Raynaud's Phenomenon. / Pope, Janet E.; Clements, Philip J.; Furst, Daniel E.; Hummers, Laura; Khanna, Dinesh; Mayes, Maureen D.; Medsger, Thomas; Seibold, James; Steen, Virginia.

A Clinician's Pearls and Myths in Rheumatology. Springer London, 2009. p. 77-95.

Research output: Chapter in Book/Report/Conference proceedingChapter

Pope, JE, Clements, PJ, Furst, DE, Hummers, L, Khanna, D, Mayes, MD, Medsger, T, Seibold, J & Steen, V 2009, Systemic Sclerosis (Scleroderma) and Raynaud's Phenomenon. in A Clinician's Pearls and Myths in Rheumatology. Springer London, pp. 77-95. https://doi.org/10.1007/978-1-84800-934-9_10
Pope JE, Clements PJ, Furst DE, Hummers L, Khanna D, Mayes MD et al. Systemic Sclerosis (Scleroderma) and Raynaud's Phenomenon. In A Clinician's Pearls and Myths in Rheumatology. Springer London. 2009. p. 77-95 https://doi.org/10.1007/978-1-84800-934-9_10
Pope, Janet E. ; Clements, Philip J. ; Furst, Daniel E. ; Hummers, Laura ; Khanna, Dinesh ; Mayes, Maureen D. ; Medsger, Thomas ; Seibold, James ; Steen, Virginia. / Systemic Sclerosis (Scleroderma) and Raynaud's Phenomenon. A Clinician's Pearls and Myths in Rheumatology. Springer London, 2009. pp. 77-95
@inbook{46774fb410994b6187b236d6986c3e7a,
title = "Systemic Sclerosis (Scleroderma) and Raynaud's Phenomenon",
abstract = "Systemic sclerosis (scleroderma; SSc) is a chronic con nective tissue disease characterized by inflammation within, and fibrosis of, the skin, vascular abnormalities, visceral damage, and the production of autoantibodies. SSc is divided generally into limited and diffuse forms, based on the extent of skin involvement. A group of conditions known as {"}localized{"} sclero-derma, which includes morphea, linear scleroderma, and en coup de sabre, is discussed in the chapter on Scleroderma Mimickers (Chap. 11). Diffuse SSc has a greater extent of skin involvement and is more likely to be associated with renal crisis, pulmonary fibrosis, and cardiomyopathy. Patients with diffuse SSc have a higher mortality rate. Pulmonary disease remains a major source of morbidity and mortality for patients with SSc. Patients with limited SSc are predisposed to the development of pulmonary arterial hypertension (PAH). Those with diffuse SSc are predisposed to interstitial fibrosis. Autoantibody profiles can predict to a certain extent the types of organ involvement that can be expected in SSc. Raynaud's phenomenon (RP) is characterized by vasospasm of the digital arteries that leads to well-demarcated pallor with cyanosis and rubor. RP is essentially universal among patients with SSc and is the first symptom in a large majority of patients. Primary RP is often mild enough not to require treatment; however, with secondary RP from SSc, there is not only vasospasm but also fixed blood vessel problems with luminal narrowing, so the ischemia can be more severe. Complications of RP in SSc can include digital ulcers often leading to infection and amputation causing pain and functional disability. Diffuse SSc often presents with puffiness of the hands associated with pain, in a way that can mimic rheumatoid arthritis. RP often occurs around the time of development of puffy hands in diffuse SSc.",
author = "Pope, {Janet E.} and Clements, {Philip J.} and Furst, {Daniel E.} and Laura Hummers and Dinesh Khanna and Mayes, {Maureen D.} and Thomas Medsger and James Seibold and Virginia Steen",
year = "2009",
doi = "10.1007/978-1-84800-934-9_10",
language = "English (US)",
isbn = "9781848009332",
pages = "77--95",
booktitle = "A Clinician's Pearls and Myths in Rheumatology",
publisher = "Springer London",

}

TY - CHAP

T1 - Systemic Sclerosis (Scleroderma) and Raynaud's Phenomenon

AU - Pope, Janet E.

AU - Clements, Philip J.

AU - Furst, Daniel E.

AU - Hummers, Laura

AU - Khanna, Dinesh

AU - Mayes, Maureen D.

AU - Medsger, Thomas

AU - Seibold, James

AU - Steen, Virginia

PY - 2009

Y1 - 2009

N2 - Systemic sclerosis (scleroderma; SSc) is a chronic con nective tissue disease characterized by inflammation within, and fibrosis of, the skin, vascular abnormalities, visceral damage, and the production of autoantibodies. SSc is divided generally into limited and diffuse forms, based on the extent of skin involvement. A group of conditions known as "localized" sclero-derma, which includes morphea, linear scleroderma, and en coup de sabre, is discussed in the chapter on Scleroderma Mimickers (Chap. 11). Diffuse SSc has a greater extent of skin involvement and is more likely to be associated with renal crisis, pulmonary fibrosis, and cardiomyopathy. Patients with diffuse SSc have a higher mortality rate. Pulmonary disease remains a major source of morbidity and mortality for patients with SSc. Patients with limited SSc are predisposed to the development of pulmonary arterial hypertension (PAH). Those with diffuse SSc are predisposed to interstitial fibrosis. Autoantibody profiles can predict to a certain extent the types of organ involvement that can be expected in SSc. Raynaud's phenomenon (RP) is characterized by vasospasm of the digital arteries that leads to well-demarcated pallor with cyanosis and rubor. RP is essentially universal among patients with SSc and is the first symptom in a large majority of patients. Primary RP is often mild enough not to require treatment; however, with secondary RP from SSc, there is not only vasospasm but also fixed blood vessel problems with luminal narrowing, so the ischemia can be more severe. Complications of RP in SSc can include digital ulcers often leading to infection and amputation causing pain and functional disability. Diffuse SSc often presents with puffiness of the hands associated with pain, in a way that can mimic rheumatoid arthritis. RP often occurs around the time of development of puffy hands in diffuse SSc.

AB - Systemic sclerosis (scleroderma; SSc) is a chronic con nective tissue disease characterized by inflammation within, and fibrosis of, the skin, vascular abnormalities, visceral damage, and the production of autoantibodies. SSc is divided generally into limited and diffuse forms, based on the extent of skin involvement. A group of conditions known as "localized" sclero-derma, which includes morphea, linear scleroderma, and en coup de sabre, is discussed in the chapter on Scleroderma Mimickers (Chap. 11). Diffuse SSc has a greater extent of skin involvement and is more likely to be associated with renal crisis, pulmonary fibrosis, and cardiomyopathy. Patients with diffuse SSc have a higher mortality rate. Pulmonary disease remains a major source of morbidity and mortality for patients with SSc. Patients with limited SSc are predisposed to the development of pulmonary arterial hypertension (PAH). Those with diffuse SSc are predisposed to interstitial fibrosis. Autoantibody profiles can predict to a certain extent the types of organ involvement that can be expected in SSc. Raynaud's phenomenon (RP) is characterized by vasospasm of the digital arteries that leads to well-demarcated pallor with cyanosis and rubor. RP is essentially universal among patients with SSc and is the first symptom in a large majority of patients. Primary RP is often mild enough not to require treatment; however, with secondary RP from SSc, there is not only vasospasm but also fixed blood vessel problems with luminal narrowing, so the ischemia can be more severe. Complications of RP in SSc can include digital ulcers often leading to infection and amputation causing pain and functional disability. Diffuse SSc often presents with puffiness of the hands associated with pain, in a way that can mimic rheumatoid arthritis. RP often occurs around the time of development of puffy hands in diffuse SSc.

UR - http://www.scopus.com/inward/record.url?scp=84889997721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889997721&partnerID=8YFLogxK

U2 - 10.1007/978-1-84800-934-9_10

DO - 10.1007/978-1-84800-934-9_10

M3 - Chapter

AN - SCOPUS:84889997721

SN - 9781848009332

SP - 77

EP - 95

BT - A Clinician's Pearls and Myths in Rheumatology

PB - Springer London

ER -